Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adele Postorino

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Frontiers in Medicine|March 13, 2023
Does Etelcalcetide reverse myelofibrotic bone changes due to hyperparathyroidism? A case reportVincenzo Antonio Panuccio, Rocco Tripepi, Adele Postorino, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|October 24, 2017
Cystic Fibrosis: A Risk Condition for Renal DiseaseDomenico Santoro, Adele Postorino, Cristina Lucanto, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Frontiers in Medicine|March 13, 2023
Does Etelcalcetide reverse myelofibrotic bone changes due to hyperparathyroidism? A case reportVincenzo Antonio Panuccio, Rocco Tripepi, Adele Postorino, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|October 24, 2017
Cystic Fibrosis: A Risk Condition for Renal DiseaseDomenico Santoro, Adele Postorino, Cristina Lucanto, et al.
Pageof 1